Local Institution
Brescia 25123
0 studies enrolling now · 16 studies all time
What they study most
Breast Cancer, Chronic Hepatitis C Infection, Chronic Myeloid Leukemia, Congestive Heart Failure, Disorder Related to Renal Transplantation, Endometrial Cancer, HIV-Associated Lipodystrophy Syndrome, Heart Failure, Hepatitis B, Chronic, Hepatitis C, Hepatitis C Virus, Hepatitis C Virus Infection
Studies at this site
- Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV — Stopped early
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting — Completed
- Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
- Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure — Completed
- Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
- Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial — Completed
- Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
- A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer — Stopped early
- Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials — Completed
- Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus — Completed
- Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection — Completed
- Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) — Completed
- Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
- A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation — Completed
- Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B — Completed
- Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome — Completed